{"id":334,"date":"2017-12-11T10:16:04","date_gmt":"2017-12-11T16:16:04","guid":{"rendered":"http:\/\/viceroyresearch.org\/?p=334"},"modified":"2020-12-16T14:44:59","modified_gmt":"2020-12-16T14:44:59","slug":"viceroy-release-mimedx-eob-emails","status":"publish","type":"post","link":"https:\/\/viceroyresearch.org\/2017\/12\/11\/viceroy-release-mimedx-eob-emails\/","title":{"rendered":"MiMedx &#8211; Viceroy release MiMedx EOB emails"},"content":{"rendered":"<p>Viceroy has obtained emails instructing physicians how to falsify MiMedx Q-codes to fraudulently increase reimbursement.<\/p>\n<p><a class=\"download-pdf-cta\" title=\"Part 20 - EOB Email\" href=\"https:\/\/viceroyresearch.org\/wp-content\/uploads\/2017\/12\/part-20-eob-email.pdf\">PDF Download Link<\/a><\/p>\n<p>Viceroy have obtained printouts of emails sent from MiMedx employees specifically instructing physicians on how to fraudulently increase Medicare reimbursement.<\/p>\n<p>An EOB document titled \u201cEpiFix &#8211; Made Easy\u201d has been sent to Viceroy, which appears to be advice from MiMedx to physicians on how to receive Medicare reimbursements for their product.<\/p>\n<p>One problem: this advice was provided to surgical clients; whose products are ineligible for Medicare reimbursement.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Viceroy has obtained emails instructing physicians how to falsify MiMedx Q-codes to fraudulently increase reimbursement&#8230;.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_links_to":"","_links_to_target":""},"categories":[61],"tags":[],"table_tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v15.6.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>MiMedx - Viceroy release MiMedx EOB emails | Viceroy Research<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/viceroyresearch.org\/2017\/12\/11\/viceroy-release-mimedx-eob-emails\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MiMedx - Viceroy release MiMedx EOB emails | Viceroy Research\" \/>\n<meta property=\"og:description\" content=\"Viceroy has obtained emails instructing physicians how to falsify MiMedx Q-codes to fraudulently increase reimbursement....\" \/>\n<meta property=\"og:url\" content=\"https:\/\/viceroyresearch.org\/2017\/12\/11\/viceroy-release-mimedx-eob-emails\/\" \/>\n<meta property=\"og:site_name\" content=\"Viceroy Research\" \/>\n<meta property=\"article:published_time\" content=\"2017-12-11T16:16:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-12-16T14:44:59+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/viceroyresearch.org\/#organization\",\"name\":\"Viceroy Research\",\"url\":\"https:\/\/viceroyresearch.org\/\",\"sameAs\":[],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/viceroyresearch.org\/#logo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/viceroyresearch.org\/wp-content\/uploads\/2020\/12\/cropped-VT-Tulip.png\",\"width\":512,\"height\":512,\"caption\":\"Viceroy Research\"},\"image\":{\"@id\":\"https:\/\/viceroyresearch.org\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/viceroyresearch.org\/#website\",\"url\":\"https:\/\/viceroyresearch.org\/\",\"name\":\"Viceroy Research\",\"description\":\"A group of individuals that see the world differently.\",\"publisher\":{\"@id\":\"https:\/\/viceroyresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":\"https:\/\/viceroyresearch.org\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/viceroyresearch.org\/2017\/12\/11\/viceroy-release-mimedx-eob-emails\/#webpage\",\"url\":\"https:\/\/viceroyresearch.org\/2017\/12\/11\/viceroy-release-mimedx-eob-emails\/\",\"name\":\"MiMedx - Viceroy release MiMedx EOB emails | Viceroy Research\",\"isPartOf\":{\"@id\":\"https:\/\/viceroyresearch.org\/#website\"},\"datePublished\":\"2017-12-11T16:16:04+00:00\",\"dateModified\":\"2020-12-16T14:44:59+00:00\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/viceroyresearch.org\/2017\/12\/11\/viceroy-release-mimedx-eob-emails\/\"]}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/viceroyresearch.org\/2017\/12\/11\/viceroy-release-mimedx-eob-emails\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/viceroyresearch.org\/2017\/12\/11\/viceroy-release-mimedx-eob-emails\/#webpage\"},\"author\":{\"@id\":\"https:\/\/viceroyresearch.org\/#\/schema\/person\/38e10fc7394949cc6e1f60bbc3ac77df\"},\"headline\":\"MiMedx &#8211; Viceroy release MiMedx EOB emails\",\"datePublished\":\"2017-12-11T16:16:04+00:00\",\"dateModified\":\"2020-12-16T14:44:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/viceroyresearch.org\/2017\/12\/11\/viceroy-release-mimedx-eob-emails\/#webpage\"},\"publisher\":{\"@id\":\"https:\/\/viceroyresearch.org\/#organization\"},\"articleSection\":\"MiMedx NASDAQ:MDXG\",\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/viceroyresearch.org\/#\/schema\/person\/38e10fc7394949cc6e1f60bbc3ac77df\",\"name\":\"Viceroy Research\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/viceroyresearch.org\/#personlogo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0031e3f514f9d4a17ee5a39a058b5d7e?s=96&d=identicon&r=g\",\"caption\":\"Viceroy Research\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","_links":{"self":[{"href":"https:\/\/viceroyresearch.org\/wp-json\/wp\/v2\/posts\/334"}],"collection":[{"href":"https:\/\/viceroyresearch.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/viceroyresearch.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/viceroyresearch.org\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/viceroyresearch.org\/wp-json\/wp\/v2\/comments?post=334"}],"version-history":[{"count":2,"href":"https:\/\/viceroyresearch.org\/wp-json\/wp\/v2\/posts\/334\/revisions"}],"predecessor-version":[{"id":4987,"href":"https:\/\/viceroyresearch.org\/wp-json\/wp\/v2\/posts\/334\/revisions\/4987"}],"wp:attachment":[{"href":"https:\/\/viceroyresearch.org\/wp-json\/wp\/v2\/media?parent=334"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/viceroyresearch.org\/wp-json\/wp\/v2\/categories?post=334"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/viceroyresearch.org\/wp-json\/wp\/v2\/tags?post=334"},{"taxonomy":"table_tags","embeddable":true,"href":"https:\/\/viceroyresearch.org\/wp-json\/wp\/v2\/table_tags?post=334"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}